Market Tracker

12/13 10:14am ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

4.35
BATS BZX Real-Time Price
As of 10:10am ET
 0.00 / 0.00%
Today’s Change
1.97
Today|||52-Week Range
5.78
+101.50%
Year-to-Date
2 Stocks Fall Tuesday
Dec 12 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close4.35
Today’s open4.25
Day’s range4.18 - 4.39
Volume967
Average volume (3 months)218,331
Market cap$241.9M
Data as of 10:10am ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)+55.10%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+28.97%
P/E ratioNM
Price/Sales2.77
Price/Book4.39

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp0.000.00%
MDWDMediwound Ltd-0.10-2.05%
SRNESorrento Therapeutic...+0.07+3.19%
TRVNTrevena Inc+0.02+1.28%
Data as of 10:13am ET, 12/13/2017

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$57.6M
Annual profit (last year)-$28.2M
Net profit margin-48.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Financial Officer
Paul J. Lytle
Vice President-Clinical &
Regulatory Affairs
Joseph S. Shan
Corporate headquarters
Tustin, California

Forecasts